ASMB Stock Price History and Quote Analysis: Insights for Investors

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ASMB shares is 37, representing 18.57% of the company's common stock.

QUBE RESEARCH & TECHNOLOGIES LTD, in the last quarter, reduced its stake in ASMB by -100% restricting it's holding to 0 shares of worth nearly N/A. ENGINEERS GATE MANAGER LP also lessened -100% of the ASMB shares from its portfolio, reducing its holding to 0 shares of worth N/A. UBS GROUP AG also shunned ASMB shares holding by -100% last quarter which brought its holding to 0 shares worth N/A.

As per its latest 13F filing, CLEAR STREET MARKETS LLC increased its stake in ASMB by 100% in the last quarter. The institutional holder raised its holding to 5 thousand shares having worth more than $4.00K. VANGUARD GROUP INC also added 4.42% more shares of ASMB to its portfolio, raising its holding to 2.34 million shares of worth $1.92M. MILLENNIUM MANAGEMENT LLC also increased its ASMB shares holding by 2.84% which brought its holding to 1.45 million shares worth $1.19M.

The insider with the most stakes in ASMB is Schornstein Alexander , 10 percent owner at the company. Additionally, ASMB stock is highly held by CEO and President Small Derek A and Chief Med. Off., VP Res. Dev. Lopatin Uri A among others.

Company executives, directors, and other insiders own 31.62% percent of Assembly Biosciences, Inc.'s stock. Within the last six months, there have been 10 transaction(s) in which ASMB insiders have sold stock, totaling 7.81K shares. Insiders that have sold shares include OKAZAKI JASON A, WHITE NICOLE S, and BJORKQUIST JEANETTE M.

There have been 4 transaction(s) during the past 6-months in which Assembly Biosciences, Inc. insiders have bought stock, totalling 198500 shares

Around 2.4M Assembly Biosciences, Inc. shares are held by insiders, which represents about 31.62% of ASMB stock.

ASMB 10 percent owner, Schornstein Alexander holds the largest portfolio of the company's shares. ASMB shares owned by Schornstein total nearly 703.11 thousand.

QUBE RESEARCH & TECHNOLOGIES LTD is the largest institutional owner in ASMB which holds 0 shares worth N/A or 0% of the total ASMB shares outstanding followed by ENGINEERS GATE MANAGER LP with ownership of 0 shares representing 0% of the ASMB ownership. UBS GROUP AG is the third largest stakeholder with 0 shares or 0% of the ownership worth more than N/A.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ASMB is concerned, it is a stock which is not optionable.

Number of ASMB shares short is 17.79K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 6.35M shares of ASMB are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ASMB has 3.84M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ASMB is 0.46.